Central composite design for validation of hptlc method for simultaneous estimation of olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in tablets

Indian Journal of Pharmaceutical Sciences

Volumn 76, Issue 3, 2014, Pages 179-187

  Solanki, Trupti ^a   Shah, Purvi ^a   Patel, Kalpana ^a  

^a ANAND PHARMACY COLLEGE   (India)

Author keywords

amlodipine besylate; central composite design; high performance thin layer chromatography; hydrochlorthiazide; Olmesartan medoxomil; validation

Indexed keywords

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; DRUG DETERMINATION; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; QUALITY CONTROL; REPRODUCIBILITY; TABLET FORMULATION; VALIDATION STUDY;

EID: 84903581558     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of world wide data. Lancet 2005;365:217-23. (Pubitemid 40138015)
2. Kakumani KK, Chimalakonda KR, Madhusudan G, Khagga M. Rapid simultaneous determination of olmesartan, Amlodipine and Hydrochlorothiazide in combined pharmaceutical dosage form by Stability-Indicating ultra performance liquid chromatography. Am J Anal Chem 2012;3:50-8.
3. Rang HP, Dale MM, Ritter JN, Moore PK. Pharmacology. 5th ed. London: Elsevier Churchill Livingstone; 2003. p. 307-13.
4. Barar FS. Essentials of Pharmacotherapeutics S. India: Chand and Company Ltd; 2004. p. 298-301, 239-49.
5. Bruton L, Parker K, Blumenthal D, Buxton I. Goodman and Gilman's Manual of pharmacology and therapeutics. USA: The McGraw Hill Companies Inc.; 2008. p. 544.
6. Tripathi KD. Essential of Medical Pharmacology. 5th ed. New Delhi: Jaypee Brothers Medical Publishers; 2003. p. 48-52.
7. Patil P, More H, Pishwikar S. RP-HPLC for simultaneous estimation of Amlodipine besylate and Olmesartan medoxomil from tablet. Int J Pharm Pharm Sci 2011;3:146-9.
8. Chabukswa A, Kuchekar B, Jagdale S, Mehetre D, More A, Lokhade P. Development and validation of a RP-HPLC method for simultaneous estimation of Olmesartan medoxomil and Amlodipine besylate in tablet dosage form. Arch Appl Sci Res 2010;2:307-12.
9. Amudhavalli V, Lakshmi K. Karthick M. Determination of Olmesartan and Hydrochlorthiazide in pharmaceutical formulations by RP-HPLC. Int J Chem Sci 2011;9:470-6.
10. Murakami T, Konno H, Fukutsu N, Onodera M, Kawasaki T, Kusu F. Identification of a degradation product in stressed tablets of olmesartan medoxomil by the complementary use of HPLC hyphenated techniques. J Pharm Biomed Anal 2008;47:553-9.
11. Rao C, Kakumani K, Maddala V, Polisetty S, Gutta M, Khagga M, et al. Development and validation of stability indicating LC method for olmesartan medoxomil. Am J Anal Chem 2012;3:153-60.
12. Jain PS, Patel MK, Gorle AP, Chaudhari AJ, Surana SJ. Stability-Indicating method for simultaneous estimation of olmesartan medoxomil, Amlodipine Besylate and Hydrochlorothiazide by RP-HPLC in tablet dosage form. J Chromatogr Sci 2012;50:680-7.
13. Patil KR, Rane VP, Sangshetti JN, Yeole RD, Shinde DB. Stability indicating LC method for the simultaneous determination of amlodipine and Olmesartan in dosage form. J Chromatogr Sci 2010;48:601-6.
14. Godse V, Bhosale A, Bafana Y, Borkar D. ICH guidance in practice: Validated stability-indicating HPLC method for simultaneous determination of Olmesartan medoxomil and Hydrochlorothiazide in combination drug products. Eurasian J Anal Chem 2010;5:137-44.
15. Shah N, Suhagia B, Shah R, Patel N. Development and validation of a simultaneous HPTLC method for the estimation of olmesartan medoxomil and hydrochlorothiazide in tablet dosage form. Indian J Pharm Sci 2007;69:834-6. (Pubitemid 351380206)
16. Bari PD, Rote AR. RP-LC and HPTLC methods for the determination of olmesartan medoxomil and Hydrochlorothiazide in combined tablet dosage forms. Chromatographia 2009;69:1469-72.
17. Sharma H, Jain N, Jain S. Development of spectrophotometric method for quantitative estimation of amlodipine besylate, Olmesartan Medoxomil and Hydrochlorthiazide in tablet dosage form. Pharm Anal Acta 2011;2:126.
18. Rote AR, Bari PD. Spectrophotometric Estimation of Olmesartan medoxomil and Hydrochlorothiazide in Tablet. Indian J Pharm Sci 2010;72:111-3.
19. Sharma H, Sahu V, Sahu R, Dandotiya N. Simultaneous spectrophotometric estimation of amlodipine besylate, olmesartan medoxomil and hydrochlorthiazide in tablet dosage form by three wavelength equation method. Int J Adv Pharm Res 2012;3:820-4.
20. Indian Pharmacopoeia. Vol. II. Ghaziabad, India: Indian Pharmacopoeia Commission; 2010. p. 1451-2.
21. British Pharmacopoeia. Vol. II. London: HMSO; 2009. p. 325-2986.
22. United State Pharmacopoeia. USP 35 and NF 30, Vol. II. Rockville, MD: United State Pharmacopoeial Commission; 2012. p. 2288.
23. Kaul N, Agrawal H, Paradkar AR, Mahadik KR. HPTLC method for determination of nevirapine in pharmaceutical dosage form. Talanta 2004;62:843-52.
24. Swarbrick J. Encyclopedia of pharmaceutical technology. 3rd ed., vol. 1. London, UK: Informa Healthcare Inc; 2007. p. 2452-67.
25. Deming SN, Morgan SL. Experimental design: A chemometrical approach. Amsterdam: Elsevier; 2003.
26. Srinubabu G, Jaganbabu K, Sudharani B, Venugopal K, Girizasankar G, Rao JV. Development and validation of a LC method for the determination of Pramipexole using an experimental design. Chromatographia 2006;64:95.
27. Srinubabu G, Raju CH, Sarath N, Kumar PK, Rao JV. Development and validation of a HPLC method for the determination of Voriconazole in pharmaceutical formulation using experimental design. Talanta 2007;71:1424-9. (Pubitemid 46161675)
28. Vander Heyden Y, Nijhuis A, Smeyers-Verbeke J, Vandeginste BG, Massart DL. Guidance for Robustness/Ruggedness tests in method validation. J Pharm Biomed Anal 2001;24:723-53. (Pubitemid 32209131)
29. Harang V, Karlsson A, Josefson M. Liquid chromatography method development and optimization by statistical experimental design and chromatogram. Chromatographia 2001;54:703.
30. Vladimir W, Anthony F. Central composite design as a powerful optimization technique for enantioresolution of the rac-11-dihydrooracin-the principal metabolite of the potential cytostatic drug oracin. J Biochem Biophys Methods 2002;54:377-90.
31. De Beer JO, Vandenbroucke CV, Massart DL, De Spiegeleer BM. Half-fraction and full factorial designs versus central composite design for retention modeling in reversed phase ion-pair liquid chromatography. J Pharm Biomed Anal 1996;14:525.
32. ICH Harmonized Tripartite Guideline, Validation of analytical procedures: Text and Methodology Q2 (R1), International Conference on Harmonization. Geneva, Switzerland, 2005.
33. Zar JH. Biostatistical analysis. 5th ed. Upper saddle River NJ, USA: Pearson Educational Publications; 2010.